首页 | 本学科首页   官方微博 | 高级检索  
     

慢性肾脏病未透析患者氧化应激状态及血清番茄红素水平研究
引用本文:黄昕,葛懿云,张怡琼,李俊旋,谢良民. 慢性肾脏病未透析患者氧化应激状态及血清番茄红素水平研究[J]. 同济大学学报(医学版), 2013, 34(6): 17-20
作者姓名:黄昕  葛懿云  张怡琼  李俊旋  谢良民
作者单位:同济大学附属东方医院营养科,上海200120
基金项目:上海市教委科研创新项目(14ZZ043)(致谢:本研究番茄红素测定得到同济大学医学院戴秋萍老师研究组的大力帮助,特此致谢.)
摘    要:目的研究慢性肾脏病(chronic kidney disease, CKD)未透析患者氧化应激状态及血清番茄红素水平。方法选取CKD未透析患者28例,入职健康体检者31例。清晨空腹采血,检测氧化和抗氧化指标丙二醛(MDA)、总抗氧化力(T—AOC)和超氧化物歧化酶(SOD)及三酰甘油(TG)、胆固醇(XC)、高密度脂蛋白胆固醇(HDL—C)和低密度脂蛋白胆固醇(LDL—C)等血脂水平。高效液相色谱法(HPLC)检测血清番茄红素水平。结果两组血脂水平无显著性差异。CKD组血清MDA和T—AOC水平与对照组相比均有显著性差异。CKD组血清SOD水平为83.86±24.47U/ml,显著低于对照组157.18±27.34U/ml(P〈0.01)。CKD组和对照组血清番茄红素水平分别为9.854-7.95μg/dl和10.18±5.29μg/dl,两者差异无统计学意义(P〉0.05)。结论CKD未透析患者存在氧化应激,番茄红素缓解CKD患者氧化应激的作用可能不明显。

关 键 词:慢性肾脏病  氧化应激  番茄红素  血脂

Oxidative status and serum lycopene level in patients with chronic kidney disease before dialysis
HUANG Xin,GE Yi-yun,ZHANG Yi-qiong,LI Jun-xuan and XIE Liang-min. Oxidative status and serum lycopene level in patients with chronic kidney disease before dialysis[J]. Journal of Tongji University(Medical Science), 2013, 34(6): 17-20
Authors:HUANG Xin  GE Yi-yun  ZHANG Yi-qiong  LI Jun-xuan  XIE Liang-min
Affiliation:( Dept. of Nutrition, East Hospital, Tongji University, Shanghai 200120, China)
Abstract:Objective To investigate the oxidative status and serum level of lycopene in patients with chronic kidney disease (CKD)before dialysis. Methods Twenty-eight CKD patients before dialysis and 31 normal subjects were enrolled in the study and fasting blood samples were collected. Blood triacylglycerols ( TG ), total cholesterol ( TC ), high density lipoprotein-cholesterol ( HDL-C ) and low density lipoprotein-cholesterol (LDL-C) were determined. Superoxide dismutase ( SOD), total antioxidant capacity(T-AOC) and malondialdehyde(MDA) were also determined. Serum lycopene content was determined by HPLC method. Results There was no statistical difference in blood lipids between CKD group and control group. The level of SOD in CKD group was 83.86 ±24.47 U/ml, which was significantly lower than that of control group( 157.18 ±27.34 U/ml, P 〈0.01 ). The serum lycopene level of CKD group and control group was 9.85 ±7.95μg/dl and 10.18 ±5.29 μg/dl, respectively, and there was no statistical significance ( P 〉 0.05 ). Conclusion Patients with CKD before dialysis have increased oxidative status and lycopene may have no significant effect in releasing oxidative stress for CKD patients.
Keywords:chronic kidney disease  oxidative stress  lycopene  blood lipid
本文献已被 维普 等数据库收录!
点击此处可从《同济大学学报(医学版)》浏览原始摘要信息
点击此处可从《同济大学学报(医学版)》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号